Medicine News and Research

RSS

Immune modulator drugs improved clinical status, reduced deaths among patients hospitalized with COVID-19

A large randomized, placebo-controlled clinical trial led by the National Institutes of Health shows that treating adults hospitalized with COVID-19 with infliximab or abatacept - drugs widely used to treat certain autoimmune diseases - did not significantly shorten time to recovery but did substantially improve clinical status and reduce deaths.

2 Jun 2022

New study in mice shows alternate origins of plaques in Alzheimer’s disease

A breakdown in how brain cells rid themselves of waste precedes the buildup of debris-filled plaques known to occur in Alzheimer's disease, a new study in mice shows.

2 Jun 2022

KHN’s ‘What the Health?’: Washington’s slow churn

In the wake of three high-profile mass shootings in less than a month, lawmakers on Capitol Hill have renewed negotiations over legislation that could stem gun violence.

2 Jun 2022

Researchers receive $1.1 million to study the safety, efficacy of drug combination for chronic pancreatitis

Researchers from Indiana University School of Medicine are studying the safety and efficacy of a drug combination for patients with chronic pancreatitis (CP).

2 Jun 2022

Kessler scientists receive two grants from the New Jersey Commission on Brain Injury Research

Kessler scientists received two grants from the New Jersey Commission on Brain Injury Research, totaling $345,379. Nancy Chiaravalloti, PhD, and Jean Lengenfelder, PhD, were awarded pilot study grants for two separate projects aimed at improving the lives of individuals with brain injury.

2 Jun 2022

Coffee consumption may reduce the risk of acute kidney injury

If you need another reason to start the day drinking a cup of joe, a recent study by Johns Hopkins Medicine researchers has revealed that consuming at least one cup of coffee a day may reduce the risk of acute kidney injury (AKI) when compared to those who do not drink coffee.

2 Jun 2022

NIH sponsors the trial of monoclonal antibody to prevent asthma exacerbations in urban youth

The National Institutes of Health has launched a clinical trial testing whether a monoclonal antibody, dupilumab, can reduce asthma attacks and improve lung function and asthma symptoms in children with poorly controlled allergic asthma who live in low-income urban neighborhoods.

2 Jun 2022

Aerobic exercise amplifies the effects of immunotherapy to reduce pancreatic tumor growth

Aerobic exercise reprograms the immune system to reduce pancreatic tumor growth and amplify the effects of immunotherapy, a new study finds.

2 Jun 2022

Dietary supplements can slow progression of age-related macular degeneration, NIH study confirms

The Age-Related Eye Disease Studies (AREDS and AREDS2) established that dietary supplements can slow progression of age-related macular degeneration (AMD), the most common cause of blindness in older Americans. In a new report, scientists analyzed 10 years of AREDS2 data.

2 Jun 2022

Mitral annulus calcification is a predictor of mortality and a marker of valvular, cardiovascular disease

A retrospective review of more than 24,000 patients who underwent an EKG at Mayo Clinic finds that nearly one-quarter of the patients had mitral annulus calcification, a chronic degeneration of tissue at the base of the heart's mitral valve.

2 Jun 2022

Survey: Two-thirds of men believe they are naturally healthier than others

We all know we should eat well and exercise to stay healthy, but a new national survey conducted online by The Harris Poll on behalf of Orlando Health finds an alarming number of men might be skipping a simple yet critical step in a healthy lifestyle: an annual checkup with their doctor.

2 Jun 2022

UH expert in lupus reports two new discoveries

Two separate findings by a University of Houston nationally recognized expert in systemic lupus erythematosus (SLE or lupus), a chronic autoimmune disease that affects multiple organs including the kidneys, skin, joints and heart, are being reported in scientific and medical journals.

2 Jun 2022

Skirmishes over medication abortions may renew debate on state vs. federal powers

As the Supreme Court appears poised to overturn Roe v. Wade, the landmark decision that guarantees the constitutional right to an abortion, reproductive rights advocates are considering new ways to protect nationwide access to the procedure.

2 Jun 2022

Despite a first-ever ‘right-to-repair’ law, there’s no easy fix for wheelchair users

Robin Bolduc isn't the type of person who takes "no" for an answer — particularly when it comes to fixing her husband's wheelchair.

2 Jun 2022

Prenatal exposure to antiseizure drugs associated with risk of autism and intellectual disability

Women with epilepsy often need medication to prevent seizures during pregnancy. Previous studies have found an association between exposure to the antiseizure medication valproate during pregnancy and risk of autism and low IQ in the offspring.

2 Jun 2022

New online modeling hub will provide projections on health impact of COVID-19 across Europe

A new online modeling hub - launched this week - will present projections on how the COVID-19 pandemic may evolve in terms of cases, hospitalizations and deaths, thus helping countries in their pandemic planning.

2 Jun 2022

New discovery could lead to highly effective ways to treat influenza

It happens every year, especially in winter. A virus saunters into your wide-open respiratory tract, worms its way into lung cells, and, next thing you know, you're lying in bed with a fever, aches, and chills - classic symptoms of influenza, or flu.

1 Jun 2022

New SOL-INCA-AD grant extends the initial study to examine cognitive aging among Latinos

Researchers at University of California San Diego School of Medicine have received a $24.5 million grant from the National Institutes of Health (NIH)/National Institute on Aging (NIA) to continue the Study of Latinos-Investigation of Neurocognitive Aging (SOL-INCA), a 12-year assessment of cognitive and brain aging and impairment among aging Latinos.

1 Jun 2022

Newer class of antidiabetic drugs reduced risk of hospitalization for heart failure

In cardiovascular outcome trials among adults with type 2 diabetes (T2D), sodium-glucose co-transporter 2 inhibitors (SGLT-2i) have shown therapeutic promise, including reduced risk of hospitalization for heart failure compared to placebo.

1 Jun 2022

New, soft implantable probe can monitor fluctuations in brain chemicals

A new string-like implant can monitor fluctuations in brain chemicals, like a fitness tracker for the brain.

1 Jun 2022

Medicine News and Research

Immune modulator drugs improved clinical status, reduced deaths among patients hospitalized with COVID-19

New study in mice shows alternate origins of plaques in Alzheimer’s disease

KHN’s ‘What the Health?’: Washington’s slow churn

Researchers receive $1.1 million to study the safety, efficacy of drug combination for chronic pancreatitis

Kessler scientists receive two grants from the New Jersey Commission on Brain Injury Research

Coffee consumption may reduce the risk of acute kidney injury

NIH sponsors the trial of monoclonal antibody to prevent asthma exacerbations in urban youth

Aerobic exercise amplifies the effects of immunotherapy to reduce pancreatic tumor growth

Dietary supplements can slow progression of age-related macular degeneration, NIH study confirms

Mitral annulus calcification is a predictor of mortality and a marker of valvular, cardiovascular disease

Survey: Two-thirds of men believe they are naturally healthier than others

UH expert in lupus reports two new discoveries

Skirmishes over medication abortions may renew debate on state vs. federal powers

Despite a first-ever ‘right-to-repair’ law, there’s no easy fix for wheelchair users

Prenatal exposure to antiseizure drugs associated with risk of autism and intellectual disability

New online modeling hub will provide projections on health impact of COVID-19 across Europe

New discovery could lead to highly effective ways to treat influenza

New SOL-INCA-AD grant extends the initial study to examine cognitive aging among Latinos

Newer class of antidiabetic drugs reduced risk of hospitalization for heart failure

New, soft implantable probe can monitor fluctuations in brain chemicals

Everything there is to know about biosimilars eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News